Evidence map›Paper›PMID 27381829›Full record

ArticleScientific reports2016

K-Ras and cyclooxygenase-2 coactivation augments intraductal papillary mucinous neoplasm and Notch1 mimicking human pancreas lesions.

Sara Chiblak, Brigitte Steinbauer, Andrea Pohl-Arnold, Dagmar Kucher, Amir Abdollahi, Christian Schwager, Birgit Höft, Irene Esposito, Karin Müller-Decker

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm.Biochimica et biophysica acta. Reviews on cancer · 2023
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Sara ChiblakTumor Models, Deutsches Krebsforschungszentrum (DKFZ),69120 Heidelberg, Germany.
Brigitte SteinbauerTumor Models, Deutsches Krebsforschungszentrum (DKFZ),69120 Heidelberg, Germany.
Andrea Pohl-ArnoldTumor Models, Deutsches Krebsforschungszentrum (DKFZ),69120 Heidelberg, Germany.
Dagmar KucherTumor Models, Deutsches Krebsforschungszentrum (DKFZ),69120 Heidelberg, Germany.
Amir AbdollahiGerman Cancer Consortium (DKTK); Molecular &Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology (HIRO), University of Heidelberg Medical School and National Center for Tumor Diseases (NCT), DKFZ, 69120 Heidelberg, Germany.
Christian SchwagerGerman Cancer Consortium (DKTK); Molecular &Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology (HIRO), University of Heidelberg Medical School and National Center for Tumor Diseases (NCT), DKFZ, 69120 Heidelberg, Germany.
Birgit HöftBirgit Höft, Division of Cancer Epidemiology, DKFZ, 69120 Heidelberg, Germany.
Irene EspositoInstitute of Pathology, Heinrich-Heine-University of Duesseldorf, 40225 Duesseldorf, Germany.
Karin Müller-DeckerTumor Models, Deutsches Krebsforschungszentrum (DKFZ),69120 Heidelberg, Germany.
German Cancer Research Center · DEDeutschen Konsortium für Translationale Krebsforschung · DEHeidelberg University · DEDKFZ-ZMBH Alliance · DEHeinrich Heine University Düsseldorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutational activation of K-Ras is an initiating event of pancreatic ductal adenocarcinomas (PDAC) that may develop either from pancreatic intraepithelial neoplasia (PanIN) or intraductal papillary mucinous neoplasms (IPMN). Cyclooxygenase-2 (COX-2)-derived prostaglandin E2 (PGE2) is causally related to pancreatic carcinogenesis. Here, we deciphered the impact of COX-2, a key modulator of inflammation, in concert with active mutant K-Ras(G12D) on tumor burden and gene expression signature using compound mutant mouse lines. Concomitant activation of COX-2 and K-Ras(G12D) accelerated the progression of pancreatic intraepithelial lesions predominantly with a cystic papillary phenotype resembling human IPMN. Transcriptomes derived from laser capture microdissected preneoplastic lesions of single and compound mutants revealed a signature that was significantly enriched in Notch1 signaling components. In vitro, Notch1 signaling was COX-2-dependent. In line with these findings, human IPMN stratified into intestinal, gastric and pancreatobillary types displayed Notch1 immunosignals with high prevalence, especially in the gastric lesions. In conclusion, a yet unknown link between activated Ras, protumorigenic COX-2 and Notch1 in IPMN onset was unraveled.

Indexed as

AnimalsCarcinogenesisCarcinoma, Pancreatic DuctalCarcinoma, PapillaryCell Line, TumorCell ProliferationCyclooxygenase 2DinoprostoneGene Expression ProfilingGene Expression Regulation, NeoplasticGenotypeHumansInflammationMiceMutationPancreasCyclooxygenase 2DinoprostoneHras protein, mouseKRAS protein, humanNOTCH1 protein, humanNotch1 protein, mouseProto-Oncogene Proteins p21(ras)PTGS2 protein, humanPtgs2 protein, mouseReceptor, Notch1

Identifiers

PMID27381829
PMCPMC4933934
OpenAlexW2460687784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.